Pulmonary tuberculosis and diabetes mellitus: Epidemiology, pathogenesis and therapeutic management (Review)
- Authors:
- You-Fan Peng
-
Affiliations: Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P.R. China - Published online on: December 21, 2023 https://doi.org/10.3892/mi.2023.128
- Article Number: 4
-
Copyright : © Peng . This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
|
International Diabetes Federation. IDF Diabetes Atlas, 10th edition. International Diabetes Federation, Brussels, 2021. | |
|
Zheng Y, Ley SH and Hu FB: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 14:88–98. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kaparianos A, Argyropoulou E, Sampsonas F, Karkoulias K, Tsiamita M and Spiropoulos K: Pulmonary complications in diabetes mellitus. Chron Respir Dis. 5:101–108. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Ali MO: Pulmonary complications in diabetes mellitus. Mymensingh Med J. 23:603–605. 2014.PubMed/NCBI | |
|
Natarajan A, Beena PM, Devnikar AV and Mali S: A systemic review on tuberculosis. Indian J Tuberc. 67:295–311. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zheng C, Hu M and Gao F: Diabetes and pulmonary tuberculosis: A global overview with special focus on the situation in Asian countries with high TB-DM burden. Glob Health Action. 10:1–11. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Chen T, Hua Z, Yan H, Wang D, Li Z, Kang Y, Zhu N and Li C: Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: A systematic review and meta-analysis. Diabetol Metab Syndr. 13(127)2021.PubMed/NCBI View Article : Google Scholar | |
|
Mugusi F, Swai AB, Alberti KG and McLarty DG: Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle. 71:271–276. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Wu Q, Wang M, Zhang Y, Wang W, Ye TF, Liu K and Chen SH: Epidemiological characteristics and their influencing factors among pulmonary tuberculosis patients with and without diabetes mellitus: A survey study from drug resistance surveillance in east china. Front Public Health. 9(777000)2022.PubMed/NCBI View Article : Google Scholar | |
|
Lee EH, Lee JM, Kang YA, Leem AY, Kim EY, Jung JY, Park MS, Kim YS, Kim SK, Chang J and Kim SY: Prevalence and impact of diabetes mellitus among patients with active pulmonary tuberculosis in South Korea. Lung. 195:209–215. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Rahim Z, Momi MS, Saha SK, Zaman K, Uddin KN, Jamil SN, Nahar N, Khan AK, Cooreman EA, Ahmed M, et al: Pulmonary tuberculosis in patients with diabetes mellitus in Bangladesh. Int J Tuberc Lung Dis. 16:1132–1133. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Delgado-Sánchez G, García-García L, Castellanos-Joya M, Cruz-Hervert P, Ferreyra-Reyes L, Ferreira-Guerrero E, Hernández A, Ortega-Baeza VM, Montero-Campos R, Sulca JA, et al: Association of pulmonary tuberculosis and diabetes in Mexico: Analysis of the national tuberculosis registry 2000-2012. PLoS One. 10(e0129312)2015.PubMed/NCBI View Article : Google Scholar | |
|
Guo S, Lei S, Li J, Li L, Chen H and Chongsuvivatwong V: Gradient association between pulmonary tuberculosis and diabetes mellitus among households with a tuberculosis case: A contact tracing-based study. Sci Rep. 12(1854)2022.PubMed/NCBI View Article : Google Scholar | |
|
Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C and Unwin N: Diabetes and tuberculosis: The impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 7(234)2007.PubMed/NCBI View Article : Google Scholar | |
|
Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, et al: Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India. Int J Tuberc Lung Dis. 21:1280–1287. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang Q, Ma A, Han X, Zhao S, Cai J, Ma Y, Zhao J, Wang Y, Dong H, Zhao Z, et al: Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: A community based cohort study. PLoS One. 8(e82660)2013.PubMed/NCBI View Article : Google Scholar | |
|
Vallerskog T, Martens GW and Kornfeld H: Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol. 184:6275–6282. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Panda S, Seelan DM, Faisal S, Arora A, Luthra K, Palanichamy JK, Mohan A, Vikram NK, Gupta NK, Ramakrishnan L and Singh A: Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis. Eur J Immunol. 52:1595–1609. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Vance J, Santos A, Sadofsky L, Morice A and Cervantes J: Effect of high glucose on human alveolar macrophage phenotype and phagocytosis of mycobacteria. Lung. 197:89–94. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Alim MA, Sikder S, Sathkumara H, Kupz A, Rush CM, Govan BL and Ketheesan N: Dysregulation of key cytokines may contribute to increased susceptibility of diabetic mice to Mycobacterium bovis BCG infection. Tuberculosis (Edinb). 115:113–120. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Martinez N, Ketheesan N, West K, Vallerskog T and Kornfeld H: Impaired recognition of mycobacterium tuberculosis by alveolar macrophages from diabetic mice. J Infect Dis. 214:1629–1637. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Alim MA, Sikder S, Bridson TL, Rush CM, Govan BL and Ketheesan N: Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes. Tuberculosis (Edinb). 102:47–54. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Sertl K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA and Shevach EM: Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med. 163:436–451. 1986.PubMed/NCBI View Article : Google Scholar | |
|
McWilliam AS, Marsh AM and Holt PG: Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: Involvement of epithelial dendritic cells. J Virol. 71:226–236. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Holt PG, Stumbles PA and McWilliam AS: Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J Leukoc Biol. 66:272–275. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Kumar NP, Moideen K, Sivakumar S, Menon PA, Viswanathan V, Kornfeld H and Babu S: Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment. Tuberculosis (Edinb). 101:191–200. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kumar NP, Moideen K, Dhakshinraj SD, Banurekha VV, Nair D, Dolla C, Kumaran P and Babu S: Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity. Immunology. 146:243–250. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Andrade BB, Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, Sher A and Babu S: Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity. Chest. 145:1244–1254. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Raposo-García S, Guerra-Laso JM, García-García S, Juan-García J, López-Fidalgo E, Diez-Tascón C, Nebreda-Mayoral T, López-Medrano R and Rivero-Lezcano OM: Immunological response to Mycobacterium tuberculosis infection in blood from type 2 diabetes patients. Immunol Lett. 186:41–45. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, Orlova MO and Apt AS: Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun. 73:1744–1753. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Vankayalapati R and Barnes PF: Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis. 89 (Suppl 1):S77–S80. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zahran WA, Ghonaim MM, Koura BA, El-Banna H, Ali SM and El-Sheikh N: Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: Potential indicators for disease activity and prognosis. Egypt J Immunol. 13:67–78. 2006.PubMed/NCBI | |
|
Zhang Q, Xiao HP, Cui HY and Sugawara I: Significant increase in natural-killer T cells in patients with tuberculosis complicated by type 2 diabetes mellitus. J Int Med Res. 39:105–111. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB and Babu S: Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis. Immunology. 144:677–686. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cheekatla SS, Tripathi D, Venkatasubramanian S, Nathella PK, Paidipally P, Ishibashi M, Welch E, Tvinnereim AR, Ikebe M, Valluri VL, et al: NK-CD11c+ cell crosstalk in diabetes enhances IL-6-mediated inflammation during mycobacterium tuberculosis infection. PLoS Pathog. 12(e1005972)2016.PubMed/NCBI View Article : Google Scholar | |
|
Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F and Caccamo N: Functional signatures of human CD4 and CD8 T cell responses to mycobacterium tuberculosis. Front Immunol. 5(180)2014.PubMed/NCBI View Article : Google Scholar | |
|
St Paul M and Ohashi PS: The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol. 30:695–704. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mayer-Barber KD and Barber DL: Innate and adaptive cellular immune responses to mycobacterium tuberculosis infection. Cold Spring Harb Perspect Med. 5(a018424)2015.PubMed/NCBI View Article : Google Scholar | |
|
Ponnana M, Pydi S and Gaddam S: Enumeration of lymphocyte subsets during follow-up in the pulmonary tuberculosis patients with co morbid diabetes mellitus. Clin Chim Acta. 510:566–572. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB and Babu S: Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis. 208:739–7348. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, Nelwan RH, Netea MG and van Crevel R: The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis. 27:97–103. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Fernández RDV, Díaz A, Bongiovanni B, Gallucci G, Bértola D, Gardeñez W, Lioi S, Bertolin Y, Galliano R, Bay ML, et al: Evidence for a more disrupted immune-endocrine relation and cortisol immunologic influences in the context of tuberculosis and type 2 diabetes comorbidity. Front Endocrinol (Lausanne). 11(126)2020.PubMed/NCBI View Article : Google Scholar | |
|
Sun Q, Zhang Q, Xiao H, Cui H and Su B: Significance of the frequency of CD4+CD25+CD127- T-cells in patients with pulmonary tuberculosis and diabetes mellitus. Respirology. 17:876–882. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Kathamuthu GR, Kumar NP, Moideen K, Dolla C, Kumaran P and Babu S: Multi-dimensionality immunophenotyping analyses of MAIT cells expressing Th1/Th17 cytokines and cytotoxic markers in latent tuberculosis diabetes comorbidity. Pathogens. 11(87)2022.PubMed/NCBI View Article : Google Scholar | |
|
Kathamuthu GR, Kumar NP, Moideen K, Menon PA and Babu S: Decreased frequencies of Gamma/Delta T cells expressing Th1/Th17 cytokine, cytotoxic, and immune markers in latent tuberculosis-diabetes/pre-diabetes comorbidity. Front Cell Infect Microbiol. 11(756854)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wei R, Li P, Xue Y, Liu Y, Gong W and Zhao W: Impact of diabetes mellitus on the immunity of tuberculosis patients: A retrospective, cross-sectional study. Risk Manag Healthc Policy. 15:611–627. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Kumar NP, Moideen K, George PJ, Dolla C, Kumaran P and Babu S: Impaired cytokine but enhanced cytotoxic marker expression in mycobacterium tuberculosis-induced CD8+ T cells in individuals with type 2 diabetes and latent mycobacterium tuberculosis infection. J Infect Dis. 213:866–870. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Ma A, Han X, Chan L, Liang H, Litifu A and Xue F: T cell profile was altered in pulmonary tuberculosis patients with type 2 diabetes. Med Sci Monit. 24:636–642. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kumar NP, Moideen K, Viswanathan V, Kornfeld H and Babu S: Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity. Immunology. 149:87–97. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kumar S, Lakhiwal R, Singh CP, Bhandiwad C, Sharma N, Singhal V and Chakranarayan A: Study of correlation of CD4, CD8 count with tuberculous pneumonia and non tuberculous bacterial pneumonia in type 2 diabetes mellitu. J Assoc Physicians India. 70:11–12. 2022.PubMed/NCBI | |
|
Kumar NP, Moideen K, Dolla C, Kumaran P and Babu S: Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection. PLoS One. 12(e0178000)2017.PubMed/NCBI View Article : Google Scholar | |
|
Mily A, Sarker P, Taznin I, Hossain D, Haq MA, Kamal SMM, Agerberth B, Brighenti S and Raqib R: Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes. BMC Infect Dis. 20(933)2020.PubMed/NCBI View Article : Google Scholar | |
|
Guo Q, Zhang J, Li G, Liu S, Xiao G, Bi J, Li F, Zhang S, Ou M, He X, et al: Elevated antigen-specific IFN-γ responses in bronchoalveolar lavage fluid impervious to clinical comorbidities improve the pulmonary tuberculosis diagnosis. Tuberculosis (Edinb). 122(101942)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K and Saito A: Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol. 139:57–64. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Meenakshi P, Ramya S, Lavanya J, Vijayalakshmi V and Sumanlatha G: Effect of IFN-γ, IL-12 and IL-10 cytokine production and mRNA expression in tuberculosis patients with diabetes mellitus and their household contacts. Cytokine. 81:127–136. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Gan SH, KhinMar KW, Barkham TM, Koh CK, Shen L, Wang YT and Chee CB: Interferon-γ responses to Mycobacterium tuberculosis-specific antigens in diabetes mellitus. Eur Respir J. 44:805–808. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Karachunskiĭ MA, Balabolkin MI and Beglarian NR: Changes in carbohydrate metabolism in patients with tuberculosis. Vestn Ross Akad Med Nauk. 7:18–21. 1995.PubMed/NCBI(In Russian). | |
|
Chen H, Su L, Bao J, Zhang K, Li Y and Mao E: The impact of pulmonary tuberculosis on immunological and metabolic features of diabetic patients. Front Immunol. 13(973991)2022.PubMed/NCBI View Article : Google Scholar | |
|
Segura-Cerda CA, Marquina-Castillo B, Lozano-Ordaz V, Mata-Espinosa D, Barrios-Payán JA, López-Torres MO, Aceves-Sánchez MJ, Bielefeldt-Ohmann H, Hernández-Pando R and Flores-Valdez MA: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines. NPJ Vaccines. 5(21)2020.PubMed/NCBI View Article : Google Scholar | |
|
Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C and Pazos-García C: Liver glucose metabolism in humans. Biosci Rep. 36(e00416)2016.PubMed/NCBI View Article : Google Scholar | |
|
Legouis D, Faivre A, Cippà PE and de Seigneux S: Renal gluconeogenesis: An underestimated role of the kidney in systemic glucose metabolism. Nephrol Dial Transplant. 37:1417–1425. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Gray EL and Goldberg HF: Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection. Intern Med J. 46:281–287. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Becker MW, Schwambach KH, Lunardelli M and Blatt CR: Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence? World J Gastrointest Pharmacol Ther. 12:40–55. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Covic A, Golea O, Segall L, Meadipudi S, Munteanu L, Nicolicioiu M, Tudorache V, Covic M and Goldsmith DJ: A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases. J Indian Med Assoc. 102:22–25. 2004.PubMed/NCBI | |
|
Broxmeyer L: Diabetes mellitus, tuberculosis and the mycobacteria: Two millenia of enigma. Med Hypotheses. 65:433–439. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Sahakyan S, Petrosyan V and Abrahamyan L: Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: A cohort study. Int J Public Health. 65:37–43. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ahmed M, Omer I, Osman SM and Ahmed-Abakur EH: Association between pulmonary tuberculosis and Type 2 diabetes in Sudanese patients. Int J Mycobacteriol. 6:97–101. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Dou M, Kou T, Liu Y, Lv W, Han L, Wang N, Ma A, Kok FJ, Schouten EG and Wang Q: Risk of having pulmonary tuberculosis in type 2 diabetes: A hospital-based matched case-control study. Asia Pac J Clin Nutr. 30:303–310. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Gil-Santana L, Almeida-Junior JL, Oliveira CA, Hickson LS, Daltro C, Castro S, Kornfeld H, Netto EM and Andrade BB: Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: A retrospective cohort study. PLoS One. 11(e0146876)2016.PubMed/NCBI View Article : Google Scholar | |
|
Ren Y, Ren H, Tian Q, Li X and Liu Y: The relationship between computed tomography appearance of pulmonary tuberculosis and blood glucose levels in 763 diabetes mellitus patients with pulmonary tuberculosis: A comparative study. Endocrine. 76:584–592. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Buasroung P, Petnak T, Liwtanakitpipat P and Kiertiburanakul S: Prevalence of diabetes mellitus in patients with tuberculosis: A prospective cohort study. Int J Infect Dis. 116:374–379. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, Lee TI and Yu MC: The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS One. 10(e0121698)2015.PubMed/NCBI View Article : Google Scholar | |
|
Huangfu P, Ugarte-Gil C, Golub J, Pearson F and Critchley J: The effects of diabetes on tuberculosis treatment outcomes: An updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 23:783–796. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ma Y, Huang ML, Li T, DU J, Shu W, Xie SH, Wang HH, Zhu GF, Tan SY, Fu YY, et al: Role of diabetes mellitus on treatment effects in drug-susceptible initial pulmonary tuberculosis patients in China. Biomed Environ Sci. 30:671–675. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Brunton L, Chapner B and Knollmann B: In: The Pharmacological Basis of Therapeutics-Goodman and Gillman. Brunton L and Chapner B (eds). 12th edition. Mc Graw Hill Medical, San Diego, CA, 2011. | |
|
Katzung BG, Mastres SB and Trevor AJ: Basic and Clinical Pharmacology. 14th edition. Mc Graw Hill Education, Singapore, 2018. | |
|
Parida SK, Axelsson-Robertson R, Rao MV, Singh N, Master I, Lutckii A, Keshavjee S, Andersson J, Zumla A and Maeurer M: Totally drug- resistant tuberculosis and adjunct therapies. J Intern Med. 277:388–405. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Novita BD: Metformin: A review of its potential as enhancer for anti tuberculosis efficacy in diabetes mellitus-tuberculosis coinfection patients. Indian J Tuberc. 66:294–298. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, et al: Effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment. Antimicrob Agents Chemother. 62:e01383–e01318. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Babalik A, Ulus IH, Bakirci N, Kuyucu T, Arpag H, Dagyildizi L and Capaner E: Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus. Antimicrob Agents Chemother. 57:5740–5742. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Hsu AH, Lee JJ, Chiang CY, Li YH, Chen LK and Lin CB: Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan. Int J Tuberc Lung Dis. 17:354–356. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Lee YJ, Han SK, Park JH, Lee JK, Kim DK, Chung HS and Heo EY: The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus. Korean J Intern Med. 33:933–940. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Degner NR, Wang JY, Golub JE and Karakousis PC: Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment. Clin Infect Dis. 66:198–205. 2018.PubMed/NCBI View Article : Google Scholar |
